Hanmi Pharm Co Ltd

Chart & Performance

D1W1MN

P/E

28.93

P/S

3.19

EPS

13,444.46

Div Yield, %

0.06%

Shrs. gr., 5y

0.12%

Rev. gr., 5y

7.54%

Revenues

1.55t

+3.48%

Net income

170.48b

+40.53%

CFO

170.15b

-12.06%

Dividend

Jun 27, 2025250 KRW/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Profile

A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.

URL

http://www.hanmi.co.kr/

IPO date

Jul 30, 2010

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title KRW in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title KRW in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT